Logo image of FAMI

FARMMI INC (FAMI) Stock Fundamental Analysis

NASDAQ:FAMI - Nasdaq - KYG332771495 - Common Stock - Currency: USD

1.7862  -0.04 (-2.39%)

Fundamental Rating

2

Overall FAMI gets a fundamental rating of 2 out of 10. We evaluated FAMI against 91 industry peers in the Food Products industry. While FAMI seems to be doing ok healthwise, there are quite some concerns on its profitability. FAMI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

FAMI had negative earnings in the past year.
FAMI had a negative operating cash flow in the past year.
Of the past 5 years FAMI 4 years were profitable.
FAMI had negative operating cash flow in 4 of the past 5 years.
FAMI Yearly Net Income VS EBIT VS OCF VS FCFFAMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

FAMI has a worse Return On Assets (-2.49%) than 65.93% of its industry peers.
FAMI's Return On Equity of -2.74% is on the low side compared to the rest of the industry. FAMI is outperformed by 63.74% of its industry peers.
FAMI's Return On Invested Capital of 0.39% is on the low side compared to the rest of the industry. FAMI is outperformed by 62.64% of its industry peers.
FAMI had an Average Return On Invested Capital over the past 3 years of 0.66%. This is significantly below the industry average of 28.40%.
Industry RankSector Rank
ROA -2.49%
ROE -2.74%
ROIC 0.39%
ROA(3y)0.11%
ROA(5y)0.78%
ROE(3y)0.09%
ROE(5y)0.93%
ROIC(3y)0.66%
ROIC(5y)1.86%
FAMI Yearly ROA, ROE, ROICFAMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

Looking at the Operating Margin, with a value of 1.24%, FAMI is in line with its industry, outperforming 43.96% of the companies in the same industry.
FAMI's Operating Margin has declined in the last couple of years.
FAMI has a worse Gross Margin (6.04%) than 83.52% of its industry peers.
FAMI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.24%
PM (TTM) N/A
GM 6.04%
OM growth 3Y-44.49%
OM growth 5Y-34.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.56%
GM growth 5Y-19.38%
FAMI Yearly Profit, Operating, Gross MarginsFAMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

5

2. Health

2.1 Basic Checks

FAMI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FAMI has more shares outstanding
Compared to 5 years ago, FAMI has more shares outstanding
The debt/assets ratio for FAMI has been reduced compared to a year ago.
FAMI Yearly Shares OutstandingFAMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
FAMI Yearly Total Debt VS Total AssetsFAMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

FAMI has an Altman-Z score of 1.52. This is a bad value and indicates that FAMI is not financially healthy and even has some risk of bankruptcy.
FAMI has a Altman-Z score (1.52) which is in line with its industry peers.
FAMI has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
FAMI has a better Debt to Equity ratio (0.04) than 75.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACC0.12
WACC3.38%
FAMI Yearly LT Debt VS Equity VS FCFFAMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 16.10 indicates that FAMI has no problem at all paying its short term obligations.
FAMI's Current ratio of 16.10 is amongst the best of the industry. FAMI outperforms 98.90% of its industry peers.
FAMI has a Quick Ratio of 15.55. This indicates that FAMI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 15.55, FAMI belongs to the top of the industry, outperforming 98.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 16.1
Quick Ratio 15.55
FAMI Yearly Current Assets VS Current LiabilitesFAMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

FAMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -251.68%.
Looking at the last year, FAMI shows a very negative growth in Revenue. The Revenue has decreased by -41.89% in the last year.
FAMI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.50% yearly.
EPS 1Y (TTM)-251.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-949.2%
Revenue 1Y (TTM)-41.89%
Revenue growth 3Y17.74%
Revenue growth 5Y17.5%
Sales Q2Q%-44.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FAMI Yearly Revenue VS EstimatesFAMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FAMI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FAMI Price Earnings VS Forward Price EarningsFAMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

FAMI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FAMI is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.11
FAMI Per share dataFAMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FAMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FARMMI INC

NASDAQ:FAMI (7/3/2025, 7:21:14 PM)

1.7862

-0.04 (-2.39%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-22 2022-08-22/bmo
Earnings (Next)N/A N/A
Inst Owners1.13%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.23M
Analysts0
Price TargetN/A
Short Float %3.38%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.01
EV/EBITDA 5.11
EPS(TTM)-7.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-13.44
FCFYN/A
OCF(TTM)-13.42
OCFYN/A
SpS51.31
BVpS135.99
TBVpS135.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -2.74%
ROCE 0.45%
ROIC 0.39%
ROICexc 0.39%
ROICexgc 0.39%
OM 1.24%
PM (TTM) N/A
GM 6.04%
FCFM N/A
ROA(3y)0.11%
ROA(5y)0.78%
ROE(3y)0.09%
ROE(5y)0.93%
ROIC(3y)0.66%
ROIC(5y)1.86%
ROICexc(3y)0.75%
ROICexc(5y)2.1%
ROICexgc(3y)0.75%
ROICexgc(5y)2.11%
ROCE(3y)0.77%
ROCE(5y)2.34%
ROICexcg growth 3Y-45.62%
ROICexcg growth 5Y-47.84%
ROICexc growth 3Y-45.62%
ROICexc growth 5Y-47.84%
OM growth 3Y-44.49%
OM growth 5Y-34.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.56%
GM growth 5Y-19.38%
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 9.21
Cap/Depr 265.77%
Cap/Sales 0.05%
Interest Coverage 12.13
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.1
Quick Ratio 15.55
Altman-Z 1.52
F-Score2
WACC3.38%
ROIC/WACC0.12
Cap/Depr(3y)88.96%
Cap/Depr(5y)118.73%
Cap/Sales(3y)0.02%
Cap/Sales(5y)0.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-251.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-949.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.89%
Revenue growth 3Y17.74%
Revenue growth 5Y17.5%
Sales Q2Q%-44.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.17%
EBIT growth 3Y-34.64%
EBIT growth 5Y-23.41%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.86%
OCF growth 3YN/A
OCF growth 5YN/A